Cisco CEO, Emergent BioSolutions CEO & J2 Global CEO
The Dow rallied 290 points, with the S&P 500 nearing a record close and Jim Cramer is helping investors siphon meaning from the market's moves. Then, Cisco CEO Chuck Robbins checks in after earnings to break down the company's quarter. Then, Cramer's digging into biotech play, Emergent BioSolutions, with CEO Bob Kramer to check in on the company's COVID-19 treatment. Plus, as J2 Global's stock works its way back to pre-pandemic levels, how could the company move forward after reporting better than expected earnings? CEO Vivek Shah joins Cramer to talk about the company's outlook.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The Dow rallied 290 points, with the S&P 500 nearing a record close and Jim Cramer is helping investors siphon meaning from the market's moves. Then, Cisco CEO Chuck Robbins checks in after earnings to break down the company's quarter. Then, Cramer's digging into biotech play, Emergent BioSolutions, with CEO Bob Kramer to check in on the company's COVID-19 treatment. Plus, as J2 Global's stock works its way back to pre-pandemic levels, how could the company move forward after reporting better than expected earnings? CEO Vivek Shah joins Cramer to talk about the company's outlook.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.